魯証期貨(01461.HK)與泰山保險簽署戰略合作協議
魯証期貨(01461.HK)公布,公司與泰山保險簽署戰略合作協議,內容有關雙方深入合作形成「保險+期貨」市場拓展共同體,實現「保險+期貨」領域的創新突破;雙方以自身的專業優勢,建立相應的服務合作模式,共同創造商業價值和社會價值;雙方圍繞品牌影響力的提升,建立相應的互助共建模式等。
泰山保險為首家註冊地在山東的全國性保險法人機構,是山東省人民政府國有資產監督管理委員會履行出資人職責直接管理的企業,其股東為山東高速集團等16家國有企業,主要從事財產損失保險、責任保險、信用保險和保證保險等業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.